Detection of Immune Changes as a Result of Surgical Trauma in Human Subject
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Surgical trauma triggers a massive inflammatory response. Over time, both the innate and adaptive branches of the immune system are affected by surgical trauma. The purpose of this study to characterize the cellular and molecular mechanisms immune response to surgical trauma. Additionally, detailed information about patients' recovery profile will be recorded over a period of 6 weeks, with the eventual goal of linking immune responses to recovery profiles.
Mass cytometry of immune signaling events [ Time Frame: Blood samples for mass cytometry will be drawn at baseline, 1 hour post-op, 24 hours post-op, 3 days post-op, and 6 weeks post-op. ]
The primary molecular outcome is the fold change in phosphorylation of signaling proteins.
Secondary Outcome Measures :
Surgical Recovery Scale (SRS) [ Time Frame: Data will be collected at baseline, daily through the hospitalization, and every 3 days for 6 weeks. ]
The surgical recovery scale is a validated questionnaire yielding a numerical score and assessing postoperative recovery.
Western Ontario and McMaster Universities Arthritis Index (WOMAC) [ Time Frame: Data will be collected at baseline, daily through the hospitalization, and every 3 days for 6 weeks. ]
Western Ontario and McMaster Universities Arthritis Index is a validated questionnaires yielding a numerical score and assessing functional status and pain in patients suffering from osteoarthritis of the hip.
Plasma cytokines [ Time Frame: Blood samples will be drawn at baseline, 1 hour post-op, 24 hours post-op, 3 days post-op, and 6 weeks post-op. ]
The plasma concentration of plasma cytokines and chemokines will be measured with aid of a large protein array.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 90 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients undergoing primary hip replacement.
18 - 90
Planning to undergo hip surgery
Fluent in English
Willing and able to sign informed consent and HIPAA authorization
Any systemic disease that might compromise the immune system
Diagnosis of cancer within the last 5 years
Psychiatric, immunological, and neurological conditions that would interfere with the collection and interpretation of study data
Any other conditions that, in the opinion of the investigators, may compromise a participant's safety or the integrity of the study